Articles and Information
Form 7 Monthly Progress Report April 2025
Form 7 Monthly Progress Report May 2025 Name of Listed Issuer: Trading Symbol: Number of
May 6, 2025
- News
BioMark Diagnostics to Conduct Validation Studies for its Patented Assays in Patients with Lung Cancer Dr. James Bond of Surrey Memorial Hospital to act as Principal Investigator
BioMark Diagnostics Inc.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Categories
Archives
Sign up for the latest Biomark news
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Related articles ...
Articles and Information
Form 7 Monthly Progress Report March 2025
Form 7 Monthly Progress Report February 2025 Name of Listed Issuer: Trading Symbol: Number of
April 5, 2025
News
BioMark Announces the Final Closing of Oversubscribed Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. BioMark
April 1, 2025
News
BioMark Secures Financing for Initial Tranche to Advance Early-Detection Oncology Testing Platform
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. BioMark
March 26, 2025
News
Remembering Mia Love: A Trailblazer’s Legacy and Biomark’s Fight Against Cancer
Personal Reflection: A Shared Journey of Loss and Hope My journey with BioMark Diagnostics is
March 26, 2025
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2